Frequency and predictors of confirmed hypoglycaemia in type 1 and insulin-treated type 2 diabetes mellitus patients in a real-life setting: Results from the DIALOG study

Diabetes and Metabolism

Volumn 41, Issue 2, 2015, Pages 116-125

  Cariou, B ^a   Fontaine, P ^b   Eschwege, E ^c   Lievre M ^d   Gouet, D ^e   Huet, D ^f   Madani, S ^g   Lavigne, S ^h   Charbonnel, B ^a  

^a L INSTITUT DU THORAX   (France)

^b LILLE UNIVERSITY HOSPITAL   (France)

^c CENTRE FOR RESEARCH IN EPIDEMIOLOGY AND POPULATION HEALTH   (France)

^d UNIVERSITÉ LYON 1   (France)

^e SAINT LOUIS HOSPITAL   (France)

^f SAINT JOSEPH HOSPITAL   (France)

^g NOVO NORDISK A S   (Denmark)

^h ITEC Services   (France)

Author keywords

Hypoglycaemia; Observational study; Type 1 diabetes; Type 2 diabetes

Indexed keywords

ALPHA GLUCOSIDASE INHIBITOR; DIPEPTIDYL PEPTIDASE IV INHIBITOR; GLUCAGON LIKE PEPTIDE 1 RECEPTOR AGONIST; HEMOGLOBIN A1C; INSULIN; METFORMIN; SULFONYLUREA DERIVATIVE; ANTIDIABETIC AGENT;

ADULT; ARTICLE; BODY MASS; DIABETIC PATIENT; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HEALTH SURVEY; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORBIDITY; MULTICENTER STUDY (TOPIC); NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTION; PREDICTOR VARIABLE; QUESTIONNAIRE; TREATMENT DURATION; AGED; CLINICAL TRIAL; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; MULTICENTER STUDY; PREVALENCE; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; RISK FACTOR;

ADULT; AGED; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84926670200     PISSN: 12623636     EISSN: 18781780     Source Type: Journal    
DOI: 10.1016/j.diabet.2014.10.007     Document Type: Article

References (26)

1. Frier B.M., Heller S.R. Epidemiology and impact of hypoglycaemia on patients with diabetes. Translational endocrinology & metabolism: hypoglycaemia in diabetes update 2012, 3:15-47.
2. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993, 329:977-986. Diabetes Control, Complications Trial Research Group.
3. Hypoglycemia in the Diabetes Control and Complications Trial. Diabetes 1997, 46:271-286. Diabetes Control and Complications Trial Research Group.
4. Nathan D.M. The diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30years: overview. Diabetes Care 2014, 37:9-16. DCCT/EDIC Research Group.
5. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998, 352:837-853. UK Prospective Diabetes Study (UKPDS) Group.
6. Seaquist E.R., Miller M.E., Bonds D.E., Feinglos M., Goff D.C., Peterson K., et al. The impact of frequent and unrecognized hypoglycaemia on mortality in the ACCORD study. Diabetes Care 2012, 35:409-414.
7. Bruderer S.G., Bodmer M., Jick S.S., Bader G., Schlienger R.G., Meier C.R. Incidence of and risk factors for severe hypoglycaemia in treated type 2 diabetes mellitus patients in the UK-a nested case-control analysis. Diabetes Obes Metab 2014, 16:801-811.
8. Kulzer B., Seitz L., Kern W. Real-world patient-reported rates of non-severe hypoglycaemic events in Germany. Exp Clin Endocrinol Diabetes 2014, 122:167-172.
9. Donnelly L.A., Morris A.D., Frier B.M., Ellis J.D., Donnan P.T., Durrant R., et al. Frequency and predictors of hypoglycaemia in type 1 and insulin-treated type 2 diabetes: a population-based study. Diabet Med 2005, 22:749-755.
10. Henderson J.N., Allen K.V., Deary I.J., Frier B.M. Hypoglycaemia in insulin-treated type 2 diabetes: frequency, symptoms and impaired awareness. Diabet Med 2003, 20:1016-1021.
11. Pedersen-Bjergaard U., Pramming S., Heller S.R., Wallace T.M., Rasmussen A.K., Jørgensen H.V., et al. Severe hypoglycaemia in 1076 adult patients with type 1 diabetes: influence of risk markers and selection. Diabetes Metab Res Rev 2004, 20:479-486.
12. Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration. Diabetologia 2007, 50:1140-1147. UK Hypoglycaemia Study Group.
13. Davis T.M., Brown S.G., Jacobs I.G., Bulsara M., Bruce D.G., Davis W.A. Determinants of severe hypoglycaemia complicating type 2 diabetes: the Fremantle diabetes study. J Clin Endocrinol Metab 2010, 95:2240-2247.
14. Amiel S.A., Dixon T., Mann R., Jameson K. Hypoglycaemia in type 2 diabetes. Diabet Med 2008, 25:245-254.
15. McCoy R.G., Van Houten H.K., Ziegenfuss J.Y., Shah N.D., Wermers R.A., Smith S.A. Increased mortality of patients with diabetes reporting severe hypoglycaemia. Diabetes Care 2012, 35:1897-1901.
16. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008, 358:2545-2559. ACCORD Study Group.
17. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008, 358:2560-2572. ADVANCE Collaborative Group.
18. Duckworth W., Abraira C., Moritz T., Reda D., Emanuele N., Reaven P.D., et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 2009, 360:129-139.
19. Bonds D.E., Miller M.E., Bergenstal R.M., Buse J.B., Byington R.P., Cutler J.A., et al. The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study. BMJ 2010, 340:b4909.
20. Barendse S., Singh H., Frier B.M., Speight J. The impact of hypoglycaemia on quality of life and related patient-reported outcomes in type 2 diabetes: a narrative review. Diabet Med 2012, 29:293-302.
21. Inzucchi S.E., Bergenstal R.M., Buse J.B., Diamant M., Ferrannini E., Nauck M., et al. Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia 2012, 55:1577-1596.
22. Defining and reporting hypoglycaemia in diabetes: a report from the American Diabetes Association Workgroup on Hypoglycemia. Diabetes Care 2005, 28:1245-1249. Workgroup on Hypoglycemia American Diabetes Association.
23. Seaquist E.R., Anderson J., Childs B., Cryer P., Dagogo-Jack S., Fish L., et al. Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society. Diabetes Care 2013, 36:1384-1395.
24. International Society for Pharmacoepidemiology Guidelines for good pharmacoepidemiology practices (GPP), 2007 2013, [Available from: URL]. http://www.pharmacoepi.org/resources/guidelines_08027.cfm.
25. Verges B., Brun J.M., Tawil C., Alexandre B., Kerlan V. Strategies for insulin initiation: insights from the French LIGHT observational study. Diabetes Metab Res Rev 2012, 28:97-105.
26. Charbonnel B., Eschwege E., Charpentier G., Vialettes B., Chabrier G., Suissa S., et al. Insulin glargine in real use conditions in France [article in French]. Med Mal Metabol 2010, 4:169-178.